Department of Health and Social Care (DHSC) has issued a medicine supply notification for Micronised Progesterone (Utrogestan®) 100mg capsules.
MSN/2023/052
Tier 2 – medium impact
Date of issue 19th May 2023
There are intermittent supplies of micronised progesterone (Utrogestan®) 100mg capsules until late 2023, resulting in brief periods every month when this product will be unavailable
To ensure that all patients have access to treatment, a Serious Shortage Protocol (SSP) has been issued on 19/05/2023 to limit the quantity of Utrogestan® capsules supplied to patients to 2 months.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Micronised Progesterone (Utrogestan ® ) 100mg capsules appeared first on PSNC Website.